首页 | 本学科首页   官方微博 | 高级检索  
     


Long-term effects of epoprostenol on the pulmonary vasculature in idiopathic pulmonary arterial hypertension
Authors:Rich Stuart  Pogoriler Jennifer  Husain Aliya N  Toth Peter T  Gomberg-Maitland Mardi  Archer Stephen L
Affiliation:Department of Medicine, University of Chicago, Section of Cardiology, 5841 S Maryland Ave, Ste LO 8; MC 5403, Chicago, IL 60637, USA. srich@medicine.bsd.uchicago.edu
Abstract:The current treatment of pulmonary arterial hypertension (PAH) uses vasodilator drugs. Although they improve symptoms associated with PAH, their chronic effects on the pulmonary vasculature and the right ventricle (RV) in humans remain unknown. We report the autopsy findings from a patient with idiopathic PAH treated with epoprostenol successfully for 18 years. The patient died of colon cancer. The pulmonary vasculature surprisingly showed extensive changes of a proliferative vasculopathy. Immunohistochemical studies confirmed ongoing cellular proliferation. Studies of the RV demonstrated concentric hypertrophy with seemingly preserved contractility. The myocardium shifted to glycolytic metabolism. Although the long-term use of epoprostenol contributed to the patient's increased survival, it did not prevent progression of the underlying vascular disease. Remarkably, the RV was able to sustain a normal cardiac output in the face of advanced vascular pathology. The mechanisms by which the RV adapts to chronic PAH need further study.
Keywords:
本文献已被 PubMed 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号